Anticoagulants Market Size to grow by USD 20144.5 million between 2024-2028

Technavio, a leading provider of market research reports, has released its latest study on Anticoagulants Market. This report offers a comprehensive analysis of the current market trends, emerging opportunities, and key challenges.

Key Highlights:

• Market Research Overview: The global pharmaceuticals market, encompassing entities involved in research and development (R&D) or manufacturing of generic and non-generic drugs, as well as veterinary medicines, is a significant segment of the larger pharmaceuticals, equipment, supplies, biotechnology, and life sciences industry. According to Technavio, the healthcare market size is determined by the consolidated revenue generated by these sectors. Factors propelling the expansion of the pharmaceuticals market include the increasing aging population. By 2050, approximately one-quarter of the US population and by 2030 in Europe are anticipated to be over 60 years old. - The Anticoagulants Market is experiencing significant growth, fueled by the Introduction of novel oral anticoagulants. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

• Major Findings:
  • Introduction of novel oral anticoagulants
  • Growing prevalence of coagulation disorders
  • Strong side-effects of anticoagulants
  • Increasing cost of NOACs
• Growth Projections

The market size is estimated to grow by USD 20144.5 million, at a CAGR of 8.68% during the forecast period. The oral anticoagulant market faced a significant growth impediment due to the prevalent concerns surrounding their adverse side effects. These medications, while effective in preventing thrombosis, came with a high risk of bleeding complications. The absence of antidotes to counteract the effects of novel oral anticoagulants further hindered market expansion. Antidotes are essential in reversing the anticoagulant's effects and allowing the body to restore its clotting abilities. Pharmaceutical companies have recognized the need for antidotes and have initiated research and development efforts to address this unmet medical need.

For insights on company offerings- Request a sample report!

• Regional Insights

The Anticoagulants Market refers to the global industry devoted to manufacturing and distributing medications that prevent blood clotting. These drugs are essential for managing various cardiovascular conditions, including deep vein thrombosis, pulmonary embolism, and atrial fibrillation. Key market drivers include an aging population, rising prevalence of cardiovascular diseases, and increasing healthcare expenditures. Major players include Daiichi Sankyo, Pfizer, and Sanofi. Market growth is expected to remain robust due to continuous research and development efforts.

About Technavio                                                                        

Technavio is a global market research company offering comprehensive reports and insights on various industries. Our research helps businesses make informed decisions by providing actionable data and trends. Technavio is based on four simple principles: easy-to-access reports, robust industry coverage, a focus on new and emerging technologies, and competitive pricing. We believe in helping companies and executives become better equipped to make faster, sounder, and more effective decisions. Technavio is one of the most influential market research and advisory firms in the world. We work with business and technology leaders to provide cutting-edge market research and insights to companies. 

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/